Key Aussie Agency Clears Aspen Of S. Africa Acquisition Of Sigma
This article was originally published in PharmAsia News
Executive Summary
An Australian agency has given its clearance for a proposal by South Africa's Aspen Pharmacare to buy the drug division of Sigma Pharmaceuticals for U.S.$890 million